Type 2 diabetes
Conditions
Interventions
control group:The conventional dietary intervention method was adopted
intervention group:On the basis of the control group, a nurse-patient cooperation group was established with EBCD method, and dietary management was carried out during the hospital and within 3 months
Sponsors
Quanzhou first Hospital
Eligibility
Sex/Gender
All
Age
65 Years to 80 Years
Inclusion criteria
Inclusion criteria: Age criteria: Study subjects should be 65 years of age or older, which meets the definition of the elderly population. Diagnosis criteria: Participants must be diagnosed with type 2 diabetes by a clinician, according to the diagnostic criteria of the International Diabetes Federation. Type 1 diabetes, gestational diabetes, and other specific types of diabetes should be excluded. Stability: Participants should have been stable in the past 3 months, with no acute complications of diabetes or hospitalization. Blood sugar is controlled within a reasonable range without frequent dose adjustment. Complications and other conditions: Participants who had major complications or other serious chronic conditions (such as uncontrolled high blood pressure, major heart disease, malignancies, etc.) that could have had a significant impact on the study results were excluded. Cognitive and communication skills: Study subjects must have sufficient cognitive and communication skills to understand the content of the study and its purpose, and be able to sign informed consent. Voluntary Participation: Participants must voluntarily participate in the study, understand the potential benefits and risks of participating in the study, and sign an informed consent form.
Exclusion criteria
Exclusion criteria: Age discrepancies: Individuals who have not reached 65 years of age will be excluded to ensure that the study focuses on the elderly population. Diabetes type error: If, upon further examination, a diagnosis of type 1 diabetes, gestational diabetes or other specific type of diabetes is made, the inclusion criteria will not be met. Unstable condition: Patients with acute diabetes complications occurring within the last three months, or with poor blood glucose control and frequent dose adjustment will be excluded. Major complications or other conditions: The presence of major complications such as acute myocardial infarction, severe arrhythmia, severe heart disease, or other serious chronic conditions such as active stage malignancies, end-stage renal disease, which may interfere with the study results or increase the risk of participating in the study. Cognitive impairment: Individuals with significant cognitive impairment or mental illness, inability to understand study purposes and procedures, or inability to independently sign informed consent will be excluded. Participation in other clinical trials: Patients who are currently enrolled in other clinical trials, or who have participated in other clinical trials in the 3 months prior to the start of the study, will be excluded due to potential interference or safety concerns. Drug use restrictions: Patients who use drugs that may interfere with the control of their diabetes condition, such as high-dose corticosteroid therapy, or require the use of specific drugs for other conditions that may interact with the study drug or interfere with diabetes control will be excluded. Inability to comply with study protocols: Participants who are unable to visit the hospital regularly or follow study requirements due to various reasons, such as inaccessibility, family responsibilities, etc., will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| treatment compliance;living quality; | — |
Secondary
| Measure | Time frame |
|---|---|
| satisfaction;blood glucose; | — |
Countries
China
Contacts
Public ContactZhuang Yujun
Quanzhou first Hospital
Outcome results
None listed